# Black Rock Coffee Bar, Inc.: overview

BRCB · Nasdaq · CIK 2068577 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/brcb.md) · [Financials](/companies/brcb/financials.md) · [Filings](/companies/brcb/filings.md) · [Insiders](/companies/brcb/insiders.md)

Latest reported revenue: [$63.0m](/filings/0001628280-26-055868.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 12, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-055868).

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [41.5](/filings/0001628280-25-051288.md) | [42.8 d](/filings/0001628280-26-014380.md) | [44.8](/filings/0001628280-26-034266.md) | [50.4](/filings/0001628280-26-055868.md) | [51.5](/filings/0001628280-25-051288.md) | [53.6 d](/filings/0001628280-26-014380.md) | [55.5](/filings/0001628280-26-034266.md) | [63.0](/filings/0001628280-26-055868.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [7.6%](/filings/0001628280-25-051288.md) | [(0.3%) d](/filings/0001628280-26-014380.md) | [5.0%](/filings/0001628280-26-034266.md) | [6.5%](/filings/0001628280-26-055868.md) | [(12.4%)](/filings/0001628280-25-051288.md) | [3.3% d](/filings/0001628280-26-014380.md) | [4.8%](/filings/0001628280-26-034266.md) | [6.5%](/filings/0001628280-26-055868.md) |
| Net margin | % | [(1.7%)](/filings/0001628280-25-051288.md) | [(9.9%) d](/filings/0001628280-26-014380.md) | [0.0%](/filings/0001628280-26-034266.md) | [0.0%](/filings/0001628280-26-055868.md) | [(1.4%)](/filings/0001628280-25-051288.md) | [1.2% d](/filings/0001628280-26-014380.md) | [0.7%](/filings/0001628280-26-034266.md) | [1.9%](/filings/0001628280-26-055868.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.05)](/filings/0001628280-25-051288.md) | not reported | [0.02](/filings/0001628280-26-034266.md) | [0.06](/filings/0001628280-26-055868.md) |
| Free cash flow | $m | not reported | [0.2 d](/filings/0001628280-26-014380.md) | [(3.1)](/filings/0001628280-26-034266.md) | [(3.5) d](/filings/0001628280-26-055868.md) | [(19.2) d](/filings/0001628280-25-051288.md) | [(6.9) d](/filings/0001628280-26-014380.md) | [(9.4)](/filings/0001628280-26-034266.md) | [(4.5) d](/filings/0001628280-26-055868.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [133](/filings/0001628280-26-014380.md) | [161](/filings/0001628280-26-014380.md) | [200](/filings/0001628280-26-014380.md) |
| Gross margin | % | not reported | not reported | not reported |
| Operating margin | % | [1.5%](/filings/0001628280-26-014380.md) | [3.7%](/filings/0001628280-26-014380.md) | [0.4%](/filings/0001628280-26-014380.md) |
| Net margin | % | [(6.6%)](/filings/0001628280-26-014380.md) | [(4.5%)](/filings/0001628280-26-014380.md) | [(0.0%)](/filings/0001628280-26-014380.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.00](/filings/0001628280-26-014380.md) |
| Free cash flow | $m | [(11.0)](/filings/0001628280-26-014380.md) | [(8.9)](/filings/0001628280-26-014380.md) | [(32.7)](/filings/0001628280-26-014380.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/brcb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $24.7m | 2,977,719 |  | Added +1,816,016 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $15.1m | 1,824,391 |  | Added +8,219 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $9.4m | 1,135,726 |  | Added +74,547 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $7.8m | 946,693 |  | Added +589,908 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.6m | 796,574 |  | Added +116,604 |
| [EMERALD ADVISERS, LLC](/funds/1015083.md) | 2026-06-30 | $6.2m | 742,337 |  | Reduced −7,289 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $5.5m | 661,497 |  | Reduced −237 |
| [Qube Research & Technologies Ltd](/funds/1729829.md) | 2026-06-30 | $4.4m | 534,990 |  | Added +513,593 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $4.0m | 477,835 |  | Added +98,157 |
| [EMERALD MUTUAL FUND ADVISERS TRUST](/funds/1352895.md) | 2026-06-30 | $3.8m | 453,734 |  | Unchanged |

## Recent filings

[All 130 filings](/companies/brcb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-12 | 18:20 ET | [10-Q](/filings/0001628280-26-055868.md) | Quarterly report, period 2026-06-30 | 0001628280-26-055868 |
| 2026-08-11 | 16:07 ET | [8-K](/filings/0001628280-26-055690.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055690 |
| 2026-06-01 | 16:30 ET | [8-K](/filings/0001628280-26-039536.md) | 5.07 Shareholder vote results | 0001628280-26-039536 |
| 2026-05-22 | 12:52 ET | [SCHEDULE 13D/A](/filings/0001763409-26-000002.md) | Ownership report, active investor, amended | 0001763409-26-000002 |
| 2026-05-21 | 21:23 ET | [SCHEDULE 13D](/filings/0001763409-26-000001.md) | Ownership report, active investor | 0001763409-26-000001 |
| 2026-05-20 | 16:40 ET | [8-K](/filings/0001628280-26-036943.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001628280-26-036943 |
| 2026-05-19 | 08:00 ET | [SCHEDULE 13D/A](/filings/0001493152-26-024349.md) | Ownership report, active investor, amended | 0001493152-26-024349 |
| 2026-05-13 | 18:50 ET | [10-Q](/filings/0001628280-26-034266.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034266 |
| 2026-05-12 | 16:17 ET | [8-K](/filings/0001628280-26-034126.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034126 |
| 2026-04-16 | 08:32 ET | [DEF 14A](/filings/0001628280-26-025374.md) | Proxy statement, period 2026-05-27 | 0001628280-26-025374 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001628280-26-014380.md), filed Mar 4, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/152cd102-2ded-4f7a-8705-ad4eb982d610)

## About the filer

- CIK: 2068577
- Tickers: BRCB
- Exchange: Nasdaq
- SIC code: 5810 Retail-Eating & Drinking Places
- State of incorporation: TX
- Filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:31 ET. No prices; not investment advice.